Your browser doesn't support javascript.
loading
MicroRNAs in type 2 immunity.
Johansson, Kristina; Weidner, Julie; Rådinger, Madeleine.
Afiliação
  • Johansson K; Krefting Research Centre, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
  • Weidner J; Krefting Research Centre, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
  • Rådinger M; Krefting Research Centre, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden. Electronic address: madeleine.radinger@gu.se.
Cancer Lett ; 425: 116-124, 2018 07 01.
Article em En | MEDLINE | ID: mdl-29604393
ABSTRACT
Type 2 immunity drives the pathology of allergic diseases and is necessary for expulsion of parasitic worms as well as having important implications in tumor progression. Over the last decade, a new research field has emerged describing a significant link between type 2 immunity and cancer development, called AllergoOncology. Thus, type 2 immune responses must be carefully regulated to mediate effective protection against damaging environmental factors, yet avoid excessive activation and immunopathology. Regulation of gene expression by microRNAs is required for normal behavior of most mammalian cells and has been studied extensively in the context of cancer. Although microRNA regulation of the immune system in cancer is well established and includes type 2 immune reactions in the tumor microenvironment, the involvement of microRNAs in these responses initiated by allergens, parasites or other environmental factors is just emerging. In this review, we focus on recent advances which increase the understanding of microRNA-mediated regulation of key mechanisms of type 2 immunity.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: MicroRNAs / Hipersensibilidade Imediata / Neoplasias Limite: Animals / Humans Idioma: En Revista: Cancer Lett Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: MicroRNAs / Hipersensibilidade Imediata / Neoplasias Limite: Animals / Humans Idioma: En Revista: Cancer Lett Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suécia